Acomplia is a diet pill manufactured by Sanofi Aventis for weight loss treatment. Sanofi-Aventis headquartered in Paris, France, is one of the five largest pharmaceutical companies in the world, along with Pfizer, Bristol-Myers Squibb, Novartis, and GlaxoSmithKline. Sanofi-Aventis engages in the research, development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but they also develop over-the-counter medication. Sanofi-Aventis cover 7 major therapeutic areas: cardiovascular, thrombosis, oncology, diabetes, central nervous system, internal medicine and vaccines (with its subsidiary Sanofi-Pasteur). Acomplia (also known as Rimonabant or Zimulti) has been approved by European Union in the summer of 2006 and now has become the most popular treatment for weight loss.

Acomplia is also known as magic drug as it helps for smoking cessation as well as heart diseases. UK is the country where Acompila was first made and than the whole Europe wanted it as a result of a conformity made by 25-member European Union. Acomplia is an anti obesity that contains Rimonabant, as its main constituent. Rimonabant was discovered and manufactured by a French pharmaceutical company, Sanofi-Aventis. It works on the principle of targeting the CB-1 receptors, found in the Endo- cannabinoid (EC) system. In this way, with these receptors, food and tobacco may be controlled in a perfect way. When these receptors are blocked, your appetite tends to reduce. As a result you eat less than your normal appetite and therefore you star on loosing weight. And that’s a great thing when you realize that you can really loose weight! But do not forget about regular exercising, it makes miracles! And if you renounce to few calories you would make your dream come true!

The diet drug Acomplia Rimonabant may offer you a few side effects which of course will go away once you get adjusted to the Acompila treatment such as: 1. Dizziness; 2 Muscle cramp; 3 Sleep disorders; 4 Nausea; 5 Stomach upset; 6 Diarrhea.